On Oct. 8, 2022, the Renovation Ceremony of IVD kit production and R&D factory of Wuhan Healthy Biotechnology Co., Ltd. (hereinafter referred to as “Healthy Biotech") was successfully held. Wu Zuoyou from General Manager Office of Kindstar Globalgene Technology, Inc., Ruan Yun from Wuhan Newkai Biotechnology Co., Ltd., Hao Wei, General Manager of Healthy Biotech, along with leaders from various departments of Healthy Biotech and representatives of construction units attended the ceremony to witness this important moment. The factory is located in the Health Industrial Park of Gedian Economic & Technological Development Zone, where a medical device GMP clean workshop of 3,300 square meters will be built. The workshop is expected to incorporate the production line of IVD kits which includes molecular diagnosis, diagnostic antibodies and immunodiagnosis. The new factory is expected to realize a three-step leap in R&D, pilot scale and industrialization.

At present, a series of products have been developed and put into production on platforms across Q-PCR, Sanger sequencing and NGS, including genetic testing products involving myeloid hematological tumors, lymphoid hematological tumors, hematological genetic diseases, matching and other related disease classification, of which 12 products have been CE certified. With the new base built, the R&D and industrialization of reagents will be fully sped up to promote the rapid development of Healthy Biotech.